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Sensing of endogenous nucleic acids by ZBP1 induces
keratinocyte necroptosis and skin inflammation
Michael Devos1,2*, Giel Tanghe1,2*, Barbara Gilbert1,2, Evelien Dierick1,2, Maud Verheirstraeten1,2, Josephine Nemegeer1,2, Richard de Reuver1,2,
Sylvie Lefebvre1,2, Jolien De Munck1,2, Jan Rehwinkel3, Peter Vandenabeele1,2, Wim Declercq1,2**, and Jonathan Maelfait1,2**
Aberrant detection of endogenous nucleic acids by the immune system can cause inflammatory disease. The scaffold function
of the signaling kinase RIPK1 limits spontaneous activation of the nucleic acid sensor ZBP1. Consequently, loss of RIPK1 in
keratinocytes induces ZBP1-dependent necroptosis and skin inflammation. Whether nucleic acid sensing is required to
activate ZBP1 in RIPK1-deficient conditions and which immune pathways are associated with skin disease remained open
questions. Using knock-in mice with disrupted ZBP1 nucleic acid–binding activity, we report that sensing of endogenous nucleic
acids by ZBP1 is critical in driving skin pathology characterized by antiviral and IL-17 immune responses. Inducing ZBP1
expression by interferons triggers necroptosis in RIPK1-deficient keratinocytes, and epidermis-specific deletion of MLKL
prevents disease, demonstrating that cell-intrinsic events cause inflammation. These findings indicate that dysregulated
sensing of endogenous nucleic acid by ZBP1 can drive inflammation and may contribute to the pathogenesis of IL-17–driven
inflammatory skin conditions such as psoriasis.
Introduction
Erroneous detection of endogenous nucleic acids by pattern
recognition receptors (PRRs) of the innate immune system can
cause the development of inflammatory diseases. This phe-
nomenon is best described in the context of a group of human
autoinflammatory and autoimmune disorders, termed type I
interferonopathies (Crowl et al., 2017; Lee-Kirsch, 2017; Rodero
and Crow, 2016). Gain-of-function mutations in genes encoding
components of the nucleic acid sensing pathways, including
TMEM173 (stimulator of interferon genes [STING]) and IFIH1
(MDA5), result in enhanced detection of endogenous nucleic
acids (Jeremiah et al., 2014; Liu et al., 2014; Rice et al., 2014).
Conversely, loss-of-function of genes controlling nucleic acid
metabolism such as TREX1, SAMHD1, and ADAR result in the
reduced clearance of endogenous nucleic acids and trigger
spontaneous production of type I IFNs, which initiate and sus-
tain inflammatory disease development (Crow et al., 2006; Rice
et al., 2009, 2012).
The nucleic acid receptor Z-DNA binding protein 1 (ZBP1)
restricts RNA and DNA virus infection by mechanisms
including the induction of regulated necroptotic cell death
(Kuriakose and Kanneganti, 2018). Although regulated cell
death is a vital antiviral defense strategy, excessive cell death
is thought to contribute to the pathogenesis of inflammatory
diseases (Newton andManning, 2016; Pasparakis and Vandenabeele,
2015; Weinlich et al., 2017). Execution of necroptosis results in
cell membrane rupture and the release of intracellular com-
ponents including damage-associated molecular patterns,
which activate innate immune receptors, thereby initiating a
detrimental inflammatory response. The release of antigens
by dying cells may promote adaptive immune responses, further
driving autoimmune pathology and establishing chronic disease
(Galluzzi et al., 2017).
In mouse cells, the induction of necroptosis following ZBP1
engagement occurs via the direct recruitment of the serine/
threonine protein kinase RIPK3 through RIP homotypic inter-
action motifs (RHIMs), which are present in both RIPK3 and
ZBP1 (Upton et al., 2012). RIPK3 then phosphorylates mixed
lineage kinase domain-like pseudokinase (MLKL) on serine 345,
leading to its oligomerization and translocation to the plasma
membrane, where it damages the integrity of the cell membrane
(Wallach et al., 2016). In contrast to necroptosis triggered by
TNF, necroptosis downstream of ZBP1 does not require the
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kinase activity of the RHIM-containing signaling kinase RIPK1
(Upton et al., 2012). In keratinocytes, RIPK1 ablation or disruptive
mutation of the RHIM of RIPK1 induces spontaneous ZBP1-
dependent necroptosis and triggers skin inflammation, indicating
that RIPK1 acts as a molecular scaffold to inhibit ZBP1-RIPK3-MLKL
signaling in a RHIM-dependent way (Dannappel et al., 2014; Lin
et al., 2016; Newton et al., 2016).
ZBP1 contains two tandem N-terminal Z-form nucleic acid
binding (Zα)–domains, which specifically interact with double-
stranded (ds) nucleic acid helices in the Z-conformation, in-
cluding Z-RNA and Z-DNA (Herbert, 2019). Others and our
group have shown that engagement of ZBP1 upon virus infection
crucially depended on nucleic acid sensing by intact Zα-domains
(Maelfait et al., 2017; Sridharan et al., 2017; Thapa et al., 2016).
The identity of viral ZBP1 agonists remains uncertain, and viral
ribonucleoprotein complexes, RNA genomes, or viral transcripts
have been suggested to interact with the Zα-domains of ZBP1
(Guo et al., 2018; Kesavardhana et al., 2017; Maelfait et al., 2017;
Sridharan et al., 2017; Thapa et al., 2016; Zhang et al., 2020). The
importance of Z-form nucleic acid interaction with ZBP1 during
viral infection raises the question whether endogenous nucleic
acids can also stimulate ZBP1 when certain checkpoints such as
RIPK1 are compromised and whether aberrant nucleic acid
sensing by ZBP1 could provoke the development of inflamma-
tory disease.
To address this question, we crossed epidermis-specific
RIPK1-deficient mice, which developed inflammatory skin dis-
ease, to Zbp1 knock-in animals with mutated Zα-domains, ren-
dering ZBP1 unable to interact with Z-form nucleic acids
(Maelfait et al., 2017). Using this genetic approach, we show that
skin pathology critically depends on nucleic acid sensing by
ZBP1. The epidermis of keratinocyte-specific RIPK1-deficient
mice displayed enhanced expression of antiviral genes, includ-
ing Zbp1, and is characterized by infiltration of IL-17–producing
CD4 T cells and innate lymphoid cells (ILCs). Finally, in vitro
type I (IFNβ) or type II IFN (IFNγ) treatment of RIPK1-deficient
keratinocytes induced necroptosis, while RIPK1-deficient cells
expressing Zα-domain mutant ZBP1 were protected. Together,
these data suggest that endogenous nucleic acid sensing by ZBP1
triggers cell-intrinsic necroptosis of RIPK1-deficient keratino-
cytes, which initiates an inflammatory signaling cascade causing
skin pathology.
Results and discussion
Skin pathology of Ripk1EKO mice is dependent on nucleic acid
sensing by ZBP1
Mice with epidermis-specific deletion of RIPK1 develop pro-
gressive ZBP1-dependent skin inflammation (Dannappel et al.,
2014; Lin et al., 2016). To determine if nucleic acid sensing by
ZBP1 is required for skin pathology, we crossed Ripk1FL/FL
K5CreTg/+ animals (Ripk1EKO; Ramirez et al., 2004; Takahashi
et al., 2014) to mice carrying a Zbp1 allele (Zbp1Zα1α2) mutated
in the two Zα-domain coding regions, resulting in the expres-
sion of a ZBP1 protein that is unable to interact with its nucleic
acid agonist. We have previously shown that Zbp1Zα1α2/Zα1α2 mice
are susceptible to a strain of murine cytomegalovirus that does
not block necroptosis downstream of ZBP1 (Maelfait et al., 2017).
Ripk1EKO mice developed skin pathology with macroscopically
visible lesions starting 1 wk after birth (Fig. 1 A and Fig. S1 A). In
contrast, Ripk1EKO Zbp1Zα1α2/Zα1α2 animals remained lesion-free
until at least 12 wk after birth (Fig. 1 A), whereupon more
than half of the mice displayed smaller and more focal lesions
compared with Ripk1EKO littermates, and these lesions did not
develop further until 1 yr of age. One intact allele of Zbp1 was
sufficient to initiate disease development, albeit with delayed
kinetics (Fig. 1 A). ZBP1 protein levels were not affected by Zα-
domain mutation or the absence of RIPK1 in primary keratino-
cytes treated with IFNβ to induce the expression of ZBP1 (Fig. S1 B).
Importantly, the interaction between ZBP1 and RIPK3 was not
disrupted due to Zα-domain mutation as RIPK3 coimmunopreci-
pitated equally efficient with wild-type and mutant ZBP1 (Fig. S1
C). Absence of inflammation was confirmed by histological ex-
amination of skin of 4–5-wk-old Ripk1EKO Zbp1Zα1α2/Zα1α2 mice, as
shown by normal epidermal thickness (Fig. 1, B and C) and a
normal expression pattern of the epidermal differentiation mark-
ers keratin-1, -5 and -6, compared with Ripk1EKO mice (Fig. 1 B).
As previously described, Ripk1EKO mice crossed to full-body Zbp1
knock-out animals displayed a similarly rescued phenotype as the
Ripk1EKO Zbp1Zα1α2/Zα1α2 line (Fig. S1 D; Lin et al., 2016). Deletion of
Ripk3 or reducing its gene dosage by half was sufficient to establish
substantial protection, confirming that activation of RIPK3 led to
skin pathology (Fig. S1 E; Dannappel et al., 2014). Loss of RIPK3
offered better protection against lesion formation than
ZBP1 Zα-domain mutation or deficiency, indicating that other
RHIM-containing signaling complexes, most likely mediated by
TRIF (TIR domain containing adaptor inducing IFNβ), con-
tribute to disease progression (Dannappel et al., 2014). We
conclude that intact Zα-domains are crucial for ZBP1-induced
lesion formation in Ripk1EKO mice, indicating that nucleic acid
sensing by ZBP1 drives keratinocyte necroptosis in the absence
of RIPK1.
ZBP1 activation drives an IL-17 immune response in
Ripk1EKO mice
Next, we determined the presence of immune cells in inflam-
matory lesions of Ripk1EKO mice by flow cytometry (Fig. S2 A).
The total number of CD45+ leukocytes was significantly in-
creased in Ripk1EKO epidermis, and this was dependent on nu-
cleic acid sensing by ZBP1 (Fig. 2 A and Fig. S2 A). In healthy
mouse skin, γδ-TCR+ dendritic epidermal T cells constitute the
majority of leukocytes (Nielsen et al., 2017); however, their
numbers did not significantly increase in RIPK1-deficient skin
(Fig. 2 A and Fig. S2 A). In contrast, RIPK1-deficient epidermis
displayed a marked infiltration of αβ-TCR+ CD4 T cells, which
reached similar levels as dendritic epidermal T cells. The accu-
mulation of CD4 T cells depended on intact nucleic acid sensing
by ZBP1 as these cells were reduced to wild-type levels in the
epidermis of Ripk1EKO Zbp1Zα1α2/Zα1α2 mice (Fig. 2 A and Fig. S2 A).
Further quantification showed a ZBP1-dependent influx of CD8
T cells, natural killer T cells, neutrophils, and CD64+ myeloid
cells (Fig. 2 A and Fig. S2 A). In vitro activation assays on cells
isolated from the epidermis of Ripk1EKO mice revealed that the
majority of the CD4 T cells produced the cytokine IL-17A, but not
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IFNγ, identifying these cells as helper T (Th) 17 cells (Fig. 2, B and
C). A large fraction of the CD45+ leukocytes stained negative for
many of the cell surface markers used in our staining panel;
however, they produced large amounts of IL-17A and equaled
Th17 cells in total cell numbers (Fig. 2, B and C). We concluded
that these cells most likely represent type 3 ILCs (ILC3s). At 5 wk
of age, the infiltration of IL-17A–producing CD4 T cells and ILC3s
was not observed in Ripk1EKO Zbp1Zα1α2/Zα1α2 mice. However, the
epidermis of 10–12-wk-old Ripk1EKO Zbp1Zα1α2/Zα1α2 animals con-
tained increased numbers of Th17 and ILC3s (Fig. 2 C), which
coincided with the development of mild skin pathology and
correlated with the incomplete phenotypic rescue of these mice
(see Fig. 1 A). In addition, we detected ZBP1-dependent increased
messenger RNA expression of the IL-17A regulatory cytokine
IL-23 in RIPK1-deficient epidermis (Fig. 2 D). Together, these
results indicate that in the absence of RIPK1, the detection of
nucleic acids by ZBP1 triggers keratinocyte necroptosis, which
induces an IL-17–mediated inflammatory response.
Induction of MLKL-dependent necroptosis by ZBP1 in
keratinocytes drives skin inflammation in Ripk1EKO mice
ZBP1 expression is inducible by type I and type II IFNs, and its
expression is increased in RIPK1-deficient epidermis (Lin et al.,
2016). We therefore examined whether skin lesions of Ripk1EKO
mice showed a general antiviral gene signature. Indeed, messenger
RNA expression of a panel of IFN-stimulated genes (ISGs; Zbp1,
Ifi44, Isg15, and Ifit1) and type II IFN (Ifng) was enhanced in 5-wk-
old Ripk1EKO mice, and this was fully restored in a ZBP1 Zα-domain
mutant background (Fig. 3 A and Fig. S2 B). In addition, increased
expression of inflammatory cytokines (Il6, Il1b, Il1a, Il33), the che-
mokine Ccl20, and antimicrobial peptide S100a8 required intact Zα-
domains of ZBP1 (Fig. 3 A and Fig. S2 B). To determine in which
cell types ZBP1 was expressed in inflamed Ripk1EKO skin, we per-
formed immunostaining of ZBP1. In normal skin, ZBP1 expression
is restricted to a few dermal cells, probably myeloid cells such as
macrophages, which express high basal levels of ZBP1 (Lin et al.,
2016; Newton et al., 2016). In contrast, inflamed epidermis from
Ripk1EKO mice displayed strong cytosolic staining for ZBP1 in
keratinocytes (Fig. 3 B), consistent with the enhanced ZBP1
messenger RNA expression in these lesions (Fig. 3 A). The high
expression of ZBP1 in RIPK1-deficient keratinocytes could induce
MLKL-dependent necroptosis in these cells to drive skin in-
flammation in Ripk1EKO mice. To test this hypothesis, we crossed
Ripk1EKO mice toMlklFL/FL animals (Murphy et al., 2013), generating
mice lacking both RIPK1 and MLKL in keratinocytes. Similar to
complete ZBP1 deficiency, ablating MLKL specifically in keratino-
cytes profoundly attenuated the development of lesion formation
(Fig. 3 C). In addition to inducing necroptosis, ZBP1 engagement has
been reported to activate the NLRP3 inflammasome, leading to
caspase-1–dependent pyroptosis and IL-1β release (Kuriakose
Figure 1. Skin pathology of Ripk1EKO mice is dependent on nucleic acid sensing by ZBP1. (A) Kaplan–Meier plot of macroscopically visible lesion ap-
pearance of epidermis-specific RIPK1-deficient mice (Ripk1EKO), Ripk1EKO mice carrying heterozygous (Zbp1+/Zα1α2) or homozygous (Zbp1Zα1α2/Zα1α2) Zbp1 Zα-
domain mutant alleles. Littermates that did not express the keratinocyte-specific K5-Cre transgene (Ripk1FL/FL Zbp1Zα1α2/Zα1α2) were used as controls. Pictures
of lesions are shown in Fig. S1 A. ****, P < 0.0001 by log-rank test. (B) Back skin sections of 4–5-wk-old mice with indicated genotypes were stained with H&E
or immunostained for keratin-6 (K6), keratin-1 (K1), or keratin-5 (K5) antibodies and DAPI. Scale bars, 50 µm. At least four mice per genotype were analyzed.
(C)Quantification of epidermal thickness on H&E-stained sections shown in B. The line represents the mean, and dots represent individual mice. **, P < 0.01 by
Mann–Whitney U test. Data are representative of at least two independent experiments.
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et al., 2016), which may further contribute to skin inflam-
mation. However, Ripk1EKO Casp1/11−/− mice were indistin-
guishable from Ripk1EKO littermates in terms of skin lesion
development, thereby excluding a role for pyroptosis in skin
pathology (Fig. 3 D). Together, these results show that sensing
of nucleic acids by ZBP1 in keratinocytes of Ripk1EKO mice
causes MLKL-dependent necroptosis, which initiates skin
inflammation.
ZBP1 activation by endogenous nucleic acids induces
necroptosis in RIPK1-deficient keratinocytes
To establish if ZBP1 directly induced cell death of RIPK1-
deficient keratinocytes, we treated primary RIPK1-deficient
keratinocytes with type I (IFNβ) or type II IFNs (IFNγ), which
strongly induced ZBP1 protein levels (Fig. 4 A and Fig. S1 B), and
monitored cell death by measuring uptake of a cell impermeable
dye over a 48 h time course. At 12 h after treatment, RIPK1-
deficient cells (Ripk1EKO Zbp1+/+) started to die, whereas RIPK1-
sufficient Ripk1FL/FL Zbp1+/+ or Ripk1FL/FL Zbp1Zα1α2/Zα1α2 kerati-
nocytes were unaffected (Fig. 4 C). Immunoblotting revealed
that IFNγ or IFNβ treatment induced the phosphorylation of
MLKL and RIPK3 only in cells that were lacking RIPK1 and ex-
pressing wild-type ZBP1 (Fig. 4 A). In contrast, keratinocytes
derived from Ripk1EKO Zbp1Zα1α2/Zα1α2 mice were fully resistant
to IFNγ- or IFNβ-induced cell death and did not show phos-
phorylation of MLKL and RIPK3 (Fig. 4, A and C). Lentiviral
transduction of wild-type but not Zα-domain mutant ZBP1
(ZBP1Zα1α2mut) caused increased cell death of RIPK1-deficient
keratinocytes starting at 24 h after transduction, compared
with the empty vector control (Fig. S3, A and B). These data
suggest that endogenous nucleic acids activate ZBP1 in the ab-
sence of RIPK1. TNF stimulation did not induce cell death or
MLKL and RIPK3 phosphorylation in RIPK1-deficient keratino-
cytes, and treatment with poly(I:C), an agonist for TLR3 that
signals via TRIF, only modestly sensitized cells to necroptosis
and independently of nucleic acid sensing by ZBP1 (Fig. 4, B and C).
Figure 2. ZBP1 activation drives an IL-17 immune response in Ripk1EKO mice. (A) Flow cytometry analysis of leukocyte (CD45+) composition of epidermis
of mice of the indicated genotypes. The number of immune cells per square centimeter of epidermis is plotted. Each dot represents an individual mouse, and
the line represents the mean. The gating strategy is outlined in Fig. S2 B. (B and C) Epidermal cells isolated from 4–5-wk-old Ripk1FL/FL Zbp1Zα1α2/Zα1α2, Ripk1EKO
Zbp1+/+, or Ripk1EKO Zbp1Zα1α2/Zα1α2 or 10–12-wk-old Ripk1EKO Zbp1Zα1α2/Zα1α2 mice were activated with PMA and ionomycin and stained for intracellular ex-
pression of IFNγ and IL-17A. In B, representative flow cytometry plots are shown for each genotype. Panel C represents the number of IL-17A–positive immune
cells per square centimeter of epidermis. Each dot represents an individual mouse, and the line represents the mean. (D) RT-qPCR analysis of Il23a in whole
back skin of 4–5-wk-old mice of the indicated genotypes. Data in A–D are representative of two independent experiments. *, P < 0.05, **, P < 0.01, ***, P <
0.001 by Mann–Whitney U test.
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These results suggest that RIPK1 deficiency greatly sensitizes
keratinocytes to ZBP1-induced necroptosis, but not down-
stream of other RHIM-containing signaling complexes formed
after TNF receptor 1 (TNFR1) stimulation and only modestly
upon TLR3 engagement. The sensitization of RIPK1-deficient
keratinocytes to TLR3/TRIF-mediated necroptosis may ex-
plain the mild amelioration of skin inflammation in Ripk1EKO
mice by epidermis-specific deletion of TRIF (Dannappel et al.,
2014). As a control, treatment with a combination of TNF and
the pan-caspase inhibitor carbobenzoxy-valyl-alanyl-aspartyl-[O-
methyl]-fluoromethylketone (zVAD), which induces TNFR1-
dependent necroptosis, only induced MLKL and RIPK3 phos-
phorylation and cell death in RIPK1-sufficient cells (Fig. 4 D and
Fig. S3 C). Loss of RIPK1 sensitized keratinocytes to caspase-
8–dependent apoptosis induced by treating cells with TNF and
the protein synthesis inhibitor cycloheximide (CHX; Fig. 4 D
and Fig. S3 C), which is in agreement with previous reports
(Gentle et al., 2011; Kelliher et al., 1998). Spontaneous ZBP1
activation in RIPK1-deficient keratinocytes did not affect
IFNγ-induced gene expression as ISG messenger RNA ex-
pression or CXCL10 protein production did not differ between
the genotypes (Fig. S3, D and E).
In summary, we report that ZBP1 induces a cell-intrinsic
ZBP1-RIPK3-MLKL pro-necroptotic signaling cascade in RIPK1-
deficient keratinocytes resulting in inflammatory skin disease.
Disease development in Ripk1EKO mice depended on the nucleic
acid sensing capacity of ZBP1, supporting the idea that endogenous
nucleic acids function as the upstream trigger for the execution
of necroptosis. The molecular identity of the nucleic acid ago-
nist of ZBP1 under these conditions remains unknown. Two
lines of evidence favor the hypothesis that cellular nucleic ac-
ids, and not those of viral or bacterial origin, activate ZBP1.
First, cultured primary RIPK1 keratinocytes, grown in sterile
conditions, succumb to IFN-induced necroptosis, which cru-
cially depended on the nucleic acid sensing capability of ZBP1.
This is in agreement with earlier studies reporting on the
toxicity of IFNs for RIPK1-deficient fibroblasts (Dillon et al.,
2014; Kaiser et al., 2014), and which was recently shown to
depend on ZBP1 (Ingram et al., 2019; Yang et al., 2020). Second,
embryos expressing a mutant RIPK1 RHIM develop ZBP1-
RIPK3-MLKL–driven inflammatory epidermal hyperplasia at
embryonic day 18.5, before exposure to microbes at birth (Lin
et al., 2016; Newton et al., 2016). Based on our observations in
Ripk1EKO mice, we anticipate that the embryonic lethality of
RIPK1 RHIM mutant mice also requires nucleic acid sensing by
ZBP1. It is not clear at which level RIPK1 operates to suppress
ZBP1-mediated necroptosis. In the absence of an intact RHIM of
RIPK1, RIPK3 spontaneously associates with ZBP1, suggesting
that RIPK1 acts as a molecular scaffold to retain RIPK3 in an
inactive state (Lin et al., 2016; Newton et al., 2016).
We and other groups identified ZBP1 as a sensor of viral RNA
(Maelfait et al., 2017; Sridharan et al., 2017; Thapa et al., 2016).
Our current data bring forward the hypothesis that the detection
of endogenous nucleic acids by ZBP1 contributes to inflammatory
Figure 3. Induction of MLKL-dependent necroptosis by ZBP1 in keratinocytes drives skin inflammation in Ripk1EKO mice. (A) RT-qPCR analysis of
indicated ISGs, IFNγ, and pro-inflammatory genes in whole back skin of 4–5-wk-old mice of the indicated genotypes. The line represents the mean, and dots
represent individual mice. *, P < 0.05 and **, P < 0.01 by Mann–Whitney U test. (B) Immunostaining with anti-ZBP1 on back skin sections from 5–7-wk-old
Ripk1FL/FL Zbp1Zα1α2/Zα1α2, Ripk1EKO Zbp1+/+, or Ripk1EKO Zbp1Zα1α2/Zα1α2 mice. Scale bars, 50 µm. The dotted line indicates the border between the epidermis and
dermis. At least four mice per genotype were analyzed. (C) Kaplan–Meier plot of macroscopically visible lesion appearance of epidermis-specific RIPK1 and
MLKL double-deficient mice (Ripk1EKO MlklEKO). Ripk1EKO MlklEHZ mice, heterozygously expressing a functional Mlkl allele in the epidermis in a Ripk1EKO
background, developed lesions at the same rate as Ripk1EKO mice, as shown in Fig. 1 A. Littermate offspring of the indicated genotypes containing one or two
functional Ripk1 and/or Mlkl alleles did not develop lesions and are shown as controls. ****, P < 0.0001 by log-rank test. (D) Kaplan–Meier plot of macro-
scopically visible lesion appearance of epidermis-specific RIPK1 and full-body caspase-1/11 double-deficient mice (Ripk1EKO Casp1/11−/−). Caspase-1/11–
sufficient Ripk1EKO Casp1/11+/+ or Ripk1EKO Casp1/11+/− mice developed lesions at the same rate as Ripk1EKO Casp1/11−/−. Littermate offspring of the indicated
genotypes expressing one or two functional Ripk1 alleles did not develop lesions and are shown as controls. Data shown in A and B are representative of at least
two independent experiments.
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skin disease. Indeed, while this study was under review, two
other groups reported that spontaneous activation of ZBP1 by
endogenous nucleic acids caused skin and intestinal inflamma-
tion (Jiao et al., 2020; Wang et al., 2020). Whether RNA or DNA
serve as agonists for ZBP1 in RIPK1-deficient keratinocytes re-
mains to be determined. Zα-domains found in ZBP1 and the RNA
editing enzyme ADAR1 specifically bind to nucleic acids in the
Z-conformation, including Z-RNA and Z-DNA (Herbert, 2019).
How dsRNA or dsDNA is stabilized in the thermodynamically
unfavorable Z-conformation in living cells is unknown. At least
in vitro, alternating CG rather than AT sequences more readily
transition into the Z-conformation, suggesting that the sequence
context is a contributing factor (Hall et al., 1984; Wang et al.,
1979). Another possibility is that nucleic acid binding to ZBP1
promotes the stabilization of the Z-conformer. Indeed, the sec-
ond Zα2 domain of ZBP1 binds B-form DNA and facilitates its
transition into Z-DNA (Kim et al., 2011a, b). We cannot rule out
that the mutation of the Zα-domains of ZBP1 affects other
functions of ZBP1 apart from nucleic acid binding. However, our
data showing that ectopically expressed Zα-domain mutant ZBP1
still activates NF-κB (Maelfait et al., 2017) and binds to RIPK3
(see Fig. S1 C) suggest that at least the RHIM–RHIM interactions
between ZBP1 and RIPK3 remained intact.
Complete Ripk1 knock-out mice die perinatally due to un-
constrained activation of both apoptotic and necroptotic
pathways (Dillon et al., 2014; Kaiser et al., 2014; Rickard et al.,
2014b). At the epithelial barriers, there appears to be an in-
teresting dichotomy in the survival functions of RIPK1. In
intestinal epithelium, RIPK1 prevents cell death mediated by
TNF and caspase-8–dependent apoptosis (Dannappel et al.,
2014; Takahashi et al., 2014), whereas loss of RIPK1 in skin
epithelial cells unleashes ZBP1-RIPK3-MLKL–mediated nec-
roptosis (Dannappel et al., 2014). Why is one cell type more
sensitive to apoptosis and another cell type more skewed to-
ward necroptosis in the absence of RIPK1? A simple explana-
tion may be the differential expression levels of components
Figure 4. ZBP1 activation by endogenous nucleic acids induces necroptosis in RIPK1-deficient keratinocytes. (A, B, and D) Primary keratinocytes
isolated from Ripk1FL/FL Zbp1+/+, Ripk1FL/FL Zbp1Zα1α2/Zα1α2, Ripk1EKO Zbp1+/+, or Ripk1EKO Zbp1Zα1α2/Zα1α2 mice were stimulated for 18 h with 200 U/ml IFNγ, 200
U/ml IFNβ, 30 ng/ml TNF, or 25 µg/ml poly(I:C) [p(I:C)] or for 6 h with 30 ng/ml TNF with 20 µM zVAD-fmk (T + z) or 30 ng/ml TNF with 5 µg/ml CHX (T + C).
Protein expression was analyzed by Western blotting. The asterisk (*) on the phospho(P)-MLKL blot indicates a nonspecific signal. The cleaved caspase-
8 (cl-casp8) forms p45 and p20 are indicated with arrows. (C) Analysis of cell death upon stimulation with 200 U/ml IFNγ, 200 U/ml IFNβ, 30 ng/ml TNF,
or 25 µg/ml poly(I:C) by measuring relative (Rel.) Sytox Green uptake every 2 h of primary keratinocytes isolated from mice of the indicated genotype.
Solid lines represent the mean of cell death curves of two to four primary keratinocyte cultures isolated from different mice. Shaded areas indicate SEM.
*, P < 0.05 by two-way ANOVA on data from Ripk1EKO Zbp1+/+ (n = 4) and Ripk1EKO Zbp1Zα1α2/Zα1α2 (n = 4) cultures. Data shown in A–D are representative
of at least two independent experiments. Ctrl, control.
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of cell death pathways such as Fas-associated protein with
death domain (FADD), caspase-8, RIPK3, and MLKL. How-
ever, this does not appear to be the case since keratinocyte-
specific depletion of the linear ubiquitination chain assembly
complex results in TNF/caspase-8–driven apoptosis driving
dermatitis (Gerlach et al., 2011; Kumari et al., 2014; Rickard
et al., 2014a; Taraborrelli et al., 2018). Vice versa, ablation of
FADD or caspase-8 triggers necroptosis of intestinal epithe-
lial cells, leading to chronic intestinal inflammation (Günther
et al., 2011; Welz et al., 2011). A more complex scenario in
which the mode of cell death is dictated by the availability of
certain PRRs and their respective ligands together with
regulatory mechanisms imprinted by the genetic back-
ground, the tissue environment, and/or inflammatory cues is
more likely.
In most cell types, including keratinocytes, ZBP1 levels are
undetectable under steady-state conditions, and its transcription
is strongly induced by IFNs (Shaw et al., 2017). Here, we dem-
onstrate that the skin of Ripk1EKO mice displays an innate anti-
viral immune response, which is responsible for the high levels
of ZBP1 expression. Cultured RIPK1-deficient keratinocytes,
however, do not express enhanced ZBP1 levels, indicating that
keratinocyte-intrinsic triggers do not provide the cues stimu-
lating the antiviral immune response in the skin of Ripk1EKO
mice. Bacterial or viral colonization of the newborn epidermis
during parturition may engage type-I IFN, inducing nucleic
acid sensors in keratinocytes or in adjacent immune cells,
inducing ZBP1 levels above a certain toxic threshold. In ad-
dition, damage-associated molecular patterns released by
necroptotic cells can be detected by PRRs in neighboring cells,
further supporting inflammation. Once the initial trigger is
delivered, RIPK1-deficient keratinocytes undergoing ZBP1-
dependent necroptosis may set in motion an auto-amplifying
inflammatory signaling cascade establishing chronic inflam-
mation. This is reminiscent of the chronic proliferative der-
matitis phenotype of SHANK-associated RH domain interactor
(SHARPIN)–deficient mice, where the initial trigger is TNF-
induced keratinocyte cell death. Release of dsRNA from dying
cells then activates TLR3, which in SHARPIN-deficient con-
ditions causes cell death resulting in a self-promoting cycle of
inflammation (Zinngrebe et al., 2016).
We demonstrate that keratinocyte necroptosis drives IL-
17–mediated inflammation. A recent study showed that the
transgenic expression of cFLIPS, a splice variant of the cFLIPL
gene Cflar, caused the activation of ILC3s, which depended on
necroptosis of intestinal epithelial cells (Shindo et al., 2019). At
this stage, we do not know whether the IL-17 response is pro-
tective and aiding in tissue repair or whether it contributes to
disease progression and chronic skin inflammation, as seen
in patients with psoriasis (Brembilla et al., 2018; Ho and
Kupper, 2019). Future studies in IL-23– or IL-17–deficient
animals will provide clarity in this matter (Tait Wojno
et al., 2019). Finally, our observations may assign important
roles for endogenous nucleic acid sensing by ZBP1 in primary
immunodeficiency and inflammatory disease observed in
RIPK1-deficient patients (Cuchet-Lourenço et al., 2018; Li
et al., 2019).
Materials and methods
Mice
Ripk1FL/FL (Takahashi et al., 2014), Keratin-5-Cre (Ramirez et al.,
2004), Ripk3−/− (Newton et al., 2004), MlklFL/FL (Murphy et al.,
2013), Zbp1−/− (Ishii et al., 2008), Casp1/11−/− (Kuida et al., 1995),
and Zbp1Zα1α2/Zα1α2 (Maelfait et al., 2017) mice were housed in
individually ventilated cages at the VIB-UGent Center for Inflam-
mation Research in a specific pathogen–free facility. Casp1/11−/−
mice were purchased from The Jackson Laboratory (B6N.129S2-
Casp1tm1Flv/J). Ripk1FL/FL, MlklFL/FL, and Zbp1Zα1α2/Zα1α2 mice were
generated in C57Bl/6 embryonic stem (ES) cells, Keratin-5-Cre
transgenes were generated in C57Bl/6JxDBA/2J ES cells, and
Ripk3−/−, Casp1/11−/− (Kayagaki et al., 2015) and Zbp1−/− (Koehler
et al., 2020) mice were generated in 129-derived ES cells. All
lines were maintained in a C57Bl/6 background. Mouse lines that
were not generated in C57Bl/6 ES cells were backcrossed at least
10 times to a C57Bl/6 background. Littermates were used as
controls for all experiments. All experiments were conducted
following approval by the local Ethics Committee of Ghent
University.
Reagents
Mouse TNF and mouse IFNγ were produced by the VIB Protein
Service Facility. zVAD-fmk (Bachem; BACEN-1510.0005), CHX
(Sigma-Aldrich; C7698), poly(I:C) (Invivogen; tlrl-pic), mouse
IFNβ (PBL Biomedical Laboratories), and mouse CXCL10 ELISA
(Thermo Fisher Scientific; BMS6018MST) were obtained from
commercial sources.
Western blotting and immunoprecipitation
For Western blotting, cells were washed with PBS and lysed in
protein lysis buffer (50 mM Tris HCl, pH 7.5, 1% Igepal CA-630,
and 150 mM NaCl) supplemented with complete protease in-
hibitor cocktail (Roche; 11697498001) and PhosSTOP (Roche;
4906845001). Lysates were cleared by centrifugation at 16,000 g
for 15 min, and 5× Laemlli loading buffer (250 mM Tris HCl, pH
6.8, 10% SDS, 0.5% Bromophenol blue, 50% glycerol, and 20%
β-mercaptoethanol) was added to the supernatant. Finally,
samples were incubated at 95°C for 5 min and analyzed using
Tris-Glycine SDS-PAGE and semi-dry immunoblotting. For
immunoprecipitation, HEK293T cells were transfected with
Lipofectamine 2000 (Life Technologies) with N-terminally V5-
tagged mouse ZBP1 and mouse RIPK3 cloned into pcDNA3 ex-
pression vectors. 24 h after transfection, cells were washed in
PBS and lysed in protein lysis buffer. Lysates were cleared from
debris by centrifugation at 16,000 g for 15 min, and 10% of the
sample was used for input control. The remaining lysate was
incubated overnight at 4°C on a rotating wheel using anti-V5
Affinity Gel beads (Sigma-Aldrich; A7345). Beads were washed
three times with protein lysis buffer. Finally, the beads were
resuspended in 1× Laemmli buffer and incubated at 95°C for
5 min. Primary antibodies used in this study are anti-ZBP1
(Adipogen; Zippy-1), anti-RIPK1 (CST; 3493), anti-RIPK3 (Pro-
Sci; 2283), anti-MLKL (Millipore; MABC604), anti-phospho-
Thr231/Ser232-RIPK3 (CST; 57220), anti-phospho-S345-MLKL
(Abcam; 196436), anti-V5-HRP (Invitrogen; R960-25), and anti-
β-tubulin-HRP (Abcam; 21058).
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Histology and immunohistochemistry
Back skin biopsy specimens were fixed in 4% paraformaldehyde
in PBS overnight at 4°C, after which they were embedded in
paraffin and sectioned at 5 µm thickness. Sections were depar-
affinized before H&E staining using a Varistain Slide Stainer.
For determining the epidermal thickness, H&E-stained skin
sections with a length of ∼1 cm were imaged with a ZEISS Axio
Scan slide scanner. Then, the thickness of the epidermis was
measured at 10 points per skin section with the ZEISS Blue
software, and the values were expressed as the average of these
10 measurements. For immunofluorescence, sections were de-
paraffinized and rehydrated using a Varistain Slide Stainer.
Antigen retrieval was performed by boiling sections at 95°C for
10 min in antigen retrieval solution (Vector; H-3301). Slides
were then treated with 3% H2O2 in PBS for 10 min and 0.1 M
NaBH4 in PBS for 2 h at room temperature to reduce back-
ground. After washing in PBS, tissues were blocked in 1% BSA
and 1% goat serum in PBS for 30 min at room temperature.
Tissue sections were stained overnight at 4°C with following
primary antibodies: anti-K6 (Covance; PRB-169P), anti-K5 (Co-
vance; PRB-160P), anti-K1 (Covance; PRB-165P), and anti-ZBP1
(Adipogen; Zippy-1). Next, sections were incubated with donkey
anti-mouse CF633 (Gentaur; 20124–1) or goat anti-rabbit Dy-
light488 (Thermo Fisher Scientific; 35552) and DAPI (Life
Technologies; D1306) for 30 min at room temperature. Images
were acquired on a Zeiss LSM880 Fast AiryScan confocal mi-
croscope using ZEN Software (Zeiss) and processed using Fiji
(ImageJ).
Quantitative RT-PCR (RT-qPCR)
Snap-frozen back skin was homogenized on dry ice using a
mortar and pestle. Total RNA was purified using RNeasy col-
umns (Qiagen) with on-column DNase I digestion. cDNA syn-
thesis was performed using the SensiFast cDNA synthesis kit
(Bioline; BIO-65054). SensiFast SYBR No-Rox kit (Bioline; BIO-
98005) or PrimeTime qPCRMaster Mix (IDT; 1055771) was used
for cDNA amplification using a Lightcycler 480 system (Roche).
The following primers were used for SYBR-green based detec-
tion, and the median expression of Rpl13a and Hprt were used
for normalization: Ifng, forward 59-GCCAAGCGGCTGACTGA-39
and reverse 59-TCAGTGAAGTAAAGGTACAAGCTACAATCT-39;
S100a8, forward 59-GGAGTTCCTTGCGATGGTGAT-39 and re-
verse 59-CAGCCCTAGGCCAGAAGCT-39; Tnf, forward 59-CCA
CCACGCTCTTCTGTCTA-39 and reverse 59-GCTACAGGCTTG
TCACTCGAA-39; Il33, forward 59-GAGCATCCAAGGAACTTCAC-
39 and reverse 59-AGATGTCTGTGTCTTTGA-39; Isg15, forward
59-TGACGCAGACTGTAGACACG-39 and reverse 59-TGGGGCTTT
AGGCCATACTC-39; Ifit1, forward 59-CAGAAGCACACATTGAAG
AA-39 and reverse 59-TGTAAGTAGCCAGAGGAAGG-39; Ccl20,
forward 59-TGCTATCATCTTTCACACGA-39 and reverse 59-CAT
CTTCTTGACTCTTAGGCTG-39; Il6, forward 59-TTCTCTGGGAAA
TCGTGGAAA-39 and reverse 59-TCAGAATTGCCATTGCACAAC-
39; Il1a, forward 59-CCTGCAGTCCATAACCCATGA-39 and reverse
59-ACTTCTGCCTGACGAGCTTCA-39; Il1b, forward 59-CCAAAA
GATGAAGGGCTGCTT-39 and reverse 59-TCATCAGGACAGCCC
AGGTC-39; Rpl13a, forward 59-CCTGCTGCTCTCAAGGTTGTT-39
and reverse 59-TGGTTGTCACTGCCTGGTACTT-39 and Hprt,
forward 59-CAAGCTTGCTGGTGAAAAGGA-39 and reverse 59-
TGCGCTCATCTTAGGCTTTGTA-39. The following oligos were
purchased from IDT for probe-based detection, and the median
expression of Tbp and Actb were used for normalization: Zbp1,
Mm.PT.58.21951435; Ifi44, Mm.PT.58.12162024, Tbp, Mm.PT.39a.
22214839; and Actb, Mm.PT.39a.22214843.g.
Primary keratinocytes cultures
Primary keratinocytes were isolated from back skin of 4–5-wk-
old mice. Back skin was shaved with electrical clippers and
sterilized with 10% betadine and 70% ethanol. Subcutaneous fat
and muscles were removed by mechanical scrapping. Subse-
quently, the skin was carefully placed on 0.25% trypsin (GIBCO
BRL; 25050014) with dermal side downward for 2 h at 37°C.
Epidermis was separated from the dermis with a forceps, cut
into fine pieces, and incubated in fresh 0.25% trypsin for 5 min
at 37°C with rotation. After neutralization with supplemented
FAD medium (see below), the epidermal cell suspension was
filtered through a 70 µm cell strainer. The keratinocytes were
seeded on J2 3T3 feeder cells that were mitotically inactivated by
treatment with 4 µg/mlMitomycin C (Sigma-Aldrich; #M-0503)
for 2 h, in 1 µg/ml collagen I-coated falcons (Sigma-Aldrich;
5006). Keratinocytes were cultured at 32°C in a humidified at-
mosphere of 5% CO2, and medium was replaced every 2 d. After
12–14 d, the remaining J2 3T3 feeder cells were removed from
the culture by short incubation with 0.25% trypsin, and the
keratinocytes were harvested subsequently. Keratinocytes were
seeded at a density of 25,000 cells per cm2 into collagen I–coated
culture plates for cell death measurements (48-well) and
Western blot analysis (12-well). Primary mouse keratinocytes
were cultured in custom-made (Biochrom, Merck) DMEM/
Ham’s F12 (FAD) medium with low Ca2+ (50 µM) supplemented
with 10% FCS (Gibco) treated with chelex 100 resin (Bio-Rad;
142–2832), 0.18 mM adenine (Sigma-Aldrich; A2786), 0.5 µg/ml
hydrocortisone (Sigma-Aldrich; H4001), 5 µg/ml insulin (Sigma-
Aldrich; I3536), 10−10 M cholera toxin (Sigma-Aldrich; C8052),
10 ng/ml epidermal growth factor (Thermo Fisher Scientific;
53003018), 2 mM glutamine (Lonza; BE17-605F), 1 mM pyruvate
(Sigma-Aldrich; S8636), 100 U/ml penicillin and 100 µg/ml
streptomycin (Sigma-Aldrich; P4333), and 16 µg/ml gentamycin
(GIBCO BRL; 15710064).
Cell death assays
25,000 primary keratinocytes were seeded per well in 1 µg/ml
collagen I–coated 48-well plates in FAD medium. 24 h later, the
cell-impermeable dye SYTOX Green (1 µM, Thermo Fisher Sci-
entific; S7020) was added to the culture medium together with
the indicated stimuli. SYTOX Green uptake was imaged every
2 or 3 h with an IncuCyte Live-Cell Analysis system (Essen
BioScience) at 37°C. The relative percentage of SYTOX Green
cells was determined by dividing the number of SYTOX
Green–positive cells per image by the percentage of confluency
(using phase contrast images) at every time point.
Keratinocyte transduction
HEK293T were cultured in high-glucose (4,500mg/liter) DMEM
(GIBCO BRL; 41965–039) supplemented with 10% FCS and 2 mM
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glutamine (Lonza; BE17-605F). For lentivirus production,
HEK293T cells were transfected with N-terminally 3XFLAG and
V5-tagged wild-type mouse ZBP1 or Zα1α2 mutant mouse ZBP1
transducing vectors in the pLenti6 backbone (Life Technologies;
Maelfait et al., 2017) together with the pCMV delta R8.91 gag-
pol–expressing packaging plasmids and pMD2.G VSV-G–expressing
envelope plasmid. 24 h after transfection, cells were washed and
FAD medium was added. 48 h after transfection, the viral super-
natant was harvested and used to transduce 25,000mouse primary
keratinocytes seeded in 48-well plates in the presence of 8 µg/ml
polybrene (Sigma-Aldrich). The next day, viral particle–containing
medium was removed, and cell death was measured for 48 h as
described above.
Skin processing for flow cytometry analysis
A piece of shaved mouse skin (±12 cm2) was isolated from 4–5-
wk-old mice. Subcutaneous fat and muscles were removed by
mechanical scrapping with a scalpel. Subsequently, the skin was
carefully placed on 0.4 mg/ml Dispase II (Roche; 4492078001)
with the dermal side facing downward for 2 h at 37°C. Epidermis
was separated from the dermis with a forceps, cut into fine
pieces, and incubated in 2 ml enzymatic solution containing
1.5 mg/ml collagenase type IV (Worthington; LS004188) and
0.5 mg/ml Dnase I (Roche; 10104159001) for 20 min at 37°C with
shaking. After neutralization with 2% FCS RMPI medium, the
cell suspension was filtered through a 70 µm cell strainer to
obtain a single cell suspension. For detection of intercellular
cytokines, in vitro activation was performed. Single cell sus-
pension from epidermis was seeded into 96-well U-bottom plate
in RPMI 1640 medium supplemented with 10% FCS, 2 mM glu-
tamine (Lonza; BE17-605F), 1 mM sodium pyruvate (Sigma-
Aldrich; S8636), 100 U/ml penicillin and 100 µg/ml streptomy-
cin (Sigma-Aldrich; P4333), and 50 mM β-mercaptoethanol
(GIBCO BRL; 31350–010). Subsequently, the cell suspension
was stimulated with eBioscience Cell Stimulation Cocktail plus
protein transport inhibitor (eBioscience; 00–4975-03) for 4 h at
37°C in a humidified 5% CO2 incubator.
Flow cytometry
Single cell suspensions were first stained with anti-mouse CD16/
CD32 (Fc-block; BD Biosciences; 553142), and dead cells were
excluded with the Fixable Viability Dye eFluor506 (eBioscience;
65–0866-14) for 30 min at 4°C in PBS. Next, cell surface markers
were stained for 30 min at 4°C in FACS buffer (PBS, 5% FCS,
1 mM EDTA, and 0.05 sodium azide). For intracellular cytokine
analysis, cells were fixed for 20 min at 4°C using BD Cytofix/
Cytoperm (BD Biosciences; 554714) and washed twice with BD
Perm/Wash buffer (BD Biosciences; 554714). Intracellular IFNγ
and IL-17A were stained in BD Perm/Wash Buffer for 30 min at
4°C. Cells were acquired with on an LSR Fortessa or a FAC-
Symphony (BD Biosciences), and data were analyzed with
FlowJo software (Tree Star). The total number of cells was
counted using a FACSVerse (BD Biosciences). The following
fluorochrome-conjugated antibodies were used: CD3e#BUV395
(1/100; 563565), CD161#BV605 (1/300; 563220), CD4#FITC
(1/400; 557307), TCRγδ#PECF594 (1/500; 563532), CD11b#PerCP-
Cy5.5 (1/1,000; 550993), and CD44#PE (1/400; 553134) were
from BD Biosciences. CD8α#eFluor450 (1/400; 48–0081-82),
CD45#AF700 (1/200; 56–0451),MHCClass II (I-A/I-E)#FITC (1/1,000;
11–5321), CD11c#PE-Cy7 (1/500; 25–0114-82), and IL17A#APC (1/200;
17–7177-81) were from eBioscience. CD19#BV785 (1/400;
115543), CD11c#BV785 (1/200; 117336), Ter-119#BV785 (1/400;
116245), Ly-6G#BV785 (1/400; 127645), TCRβ#APC-Cy7 (1/
200; 109220), CD64(FcγRI)#BV711 (1/100; 139311), and
IFNγ#PE/Cy7 (1/300; 505825) were from Biolegend.
Statistical analyses
Statistical analyses were performed using Prism 8.2.1 (GraphPad
Software). Statistical methods are described in the figure
legends.
Online supplemental material
Fig. S1 provides additional information for Fig. 1 and shows
pictures of skin lesions of Ripk1EKO Zbp1+/+ and Ripk1EKO
Zbp1Zα1α2/Zα1α2 mice, demonstrates equal protein expression of
ZBP1 and Zα-domain mutant ZBP1 in RIPK1-deficient keratino-
cytes, and shows lesion formation of Ripk1EKO mice crossed to
Zbp1−/− and Ripk3−/− animals. Fig. S2 relates to Fig. 2 and Fig. 3
and shows the gating strategy for Fig. 2 A and additional RT-
qPCR analyses of ISGs and pro-inflammatory genes in the skin of
Ripk1EKO Zbp1+/+ and Ripk1EKO Zbp1Zα1α2/Zα1α2 mice. Fig. S3 relates
to Fig. 4 and describes cell death induction of RIPK1-deficient
primary keratinocytes after transduction with ZBP1 or after
treatment with TNF + zVAD or TNF + CHX. Fig. S3 also shows
that ISG expression in keratinocytes upon IFNγ treatment is not
affected by RIPK1 deficiency or Zα-domain mutation of ZBP1.
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Supplemental material
Figure S1. Skin pathology of Ripk1EKO mice is dependent ZBP1 and RIPK3. (A) Macroscopic appearance of shaven mice of the indicated genotypes at the
indicated age. Lesional skin is depicted by white arrows or by the dotted line. (B) Protein expression analysis by Western blotting on lysates of primary
keratinocytes isolated from mice of the indicated genotypes. Cells were stimulated for 24 h with 200 U/ml IFNβ to induce ZBP1 expression. (C) N-terminally
V5-tagged wild-type mouse ZBP1 (ZBP1WT-V5) or Zα-domain mutant ZBP1 (ZBP1Zα1α2mut-V5) and mouse RIPK3 were expressed in HEK293T cells. 24 h later,
the presence of ZBP1 and RIPK3 in V5-immunoprecipitates (IP) were analyzed by Western blotting. Protein expression in input samples is shown in the lower
panels. (D and E) Kaplan–Meier plots of lesion appearance of Ripk1EKO mice crossed to (D) ZBP1-deficient (Zbp1−/−) or (E) RIPK3-deficient (Ripk3−/−) animals. *,
P < 0.05, ****, P < 0.0001 by log–rank test. Data shown in B and C are representative of at least two independent experiments.
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Figure S2. ZBP1 activation drives antiviral and IL-17 immune responses in Ripk1EKO mice. (A) Flow cytometry gating strategy of CD45+ immune cell
subsets isolated from mice of the indicated genotypes and quantified in Fig. 2 A. (B) RT-qPCR analysis of the indicated ISGs and pro-inflammatory genes in
whole back skin of 4–5-wk-old mice of the indicated genotypes. Data are representative of two independent experiments. *, P < 0.05, **, P < 0.01 by
Mann–Whitney U test.
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Figure S3. ZBP1 activation by endogenous nucleic acids induces necroptosis in RIPK1-deficient keratinocytes. (A) Primary keratinocytes isolated from
the indicated genotypes were transduced with empty vector (EV), wild-type mouse ZBP1 (ZBP1WT) or ZBP1 in which the two Zα-domains were mutated
(ZBP1Zα1α2mut). 48 h after transduction, protein expression of ZBP1 and RIPK1 was analyzed byWestern blotting. ZBP1 was N-terminally fused to a 3XFLAG and
V5-tag. (B) Analysis of cell death by measuring Sytox Green uptake on primary keratinocytes, transduced as described in A. Measurements were performed
every 3 h starting at 24 h until 72 h after transduction. (C) Analysis of cell death upon stimulation with 30 ng/ml TNF with 20 µM zVAD-fmk (T + z) or 30 ng/ml
TNF with 5 µg/ml CHX (T + C) by measuring Sytox Green uptake every 2 h of primary keratinocytes isolated from mice of the indicated genotype. Solid lines
represent the mean of cell death curves of one to four primary keratinocyte cultures isolated from different mice. Shaded areas indicate SEM. (D) RT-qPCR
analysis of the indicated ISGs after 18 h stimulation with 200 U/ml IFNγ of primary keratinocytes isolated from mice of the indicated genotypes. (E) Mea-
surement of CXCL10 protein levels in supernatant collected from cells from D by ELISA. The dotted line indicates the detection limit. Data in A–E are rep-
resentative of two independent experiments.
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